Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
محفوظ في:
| التنسيق: | الكتروني دورية |
|---|---|
| منشور في: |
Bernstein Institutional Services LLC
|
| الوصول للمادة أونلاين: | Available in Business Source Ultimate. عرض في الأوباك |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة: Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
- Celgene Corporation SWOT Analysis
- White Book - Celgene: An Abundance of Revlimid Opportunities in Myeloma, But Maintenance Is the Biggest Driver
- Black Book - Inco: Upsides from Cost Reductions, Commodity Price Rebounds, Volume Gains & Exploration
- Bernstein Black Book - Biosimilars: Quo Vadis - A Snapshot of the Biosimilar Industry Halfway Through Its Formation
- Clinical lymphoma & myeloma
- Clinical Lymphoma and Myeloma